Search

Your search keyword '"Patrick A Coffie"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Patrick A Coffie" Remove constraint Author: "Patrick A Coffie" Topic medicine Remove constraint Topic: medicine
59 results on '"Patrick A Coffie"'

Search Results

1. Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model

2. Prevalence of hypertension and other cardiovascular disease risk factors among university students from the National Polytechnic Institute of Côte d'Ivoire: A cross-sectional study.

3. Prevalence of hepatitis B and C among female sex workers in Togo, West Africa.

4. Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.

5. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.

6. Risk factors for cervical intraepithelial neoplasia in HIV-infected women on antiretroviral treatment in Côte d'Ivoire, West Africa.

7. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.

8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

9. Prevalence of severe cardiovascular abnormalities amongst West African HIV-infected patients on antiretroviral therapy followed at a referral HIV centre

10. Incidence of Tuberculosis During the First Year of Antiretroviral Treatment in West African HIV-Infected Adults

11. Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa

12. Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo

13. Changes in viral hepatitis B screening practices over time in West African HIV clinics

14. Current Prognostic Factors of Tetanus in Abidjan: 2005-2014

15. Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study

16. Prevalence of Hepatitis B among Students from the University of Lomé, Togo in 2015

17. Effect of sex and age on outcomes among HIV-2-infected patients starting antiretroviral therapy in West Africa

18. BMJ Open

19. Exploring the Patterns of Use and Acceptability of Mobile Phones Among People Living With HIV to Improve Care and Treatment: Cross-Sectional Study in Three Francophone West African Countries

20. High prevalence of binge drinking among people living with HIV in four African countries

21. Aging with HIV: what effect on mortality and loss to follow-up in the course of antiretroviral therapy? The IeDEA West Africa Cohort Collaboration

22. Prevalence of hepatitis C among HIV-1, HIV-2 and dually reactive patients: A multi-country cross-sectional survey in West Africa

23. Issues with measuring hepatitis prevalence in resource-limited settings

24. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa

25. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa

26. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study

27. Public Health: An Emerging Specialty Among Medical Students in Francophone Sub-Saharan African Countries

28. Séroprévalence du VIH chez les usagers de drogues au Togo

29. Health Care Resource Utilization in Untreated HIV-Infected Children in A Pediatric Programme, Abidjan, Côte d'Ivoire, 2004–2009

30. Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d’Ivoire, 2010

31. Oral health and HIV infection among female sex workers in Abidjan, Côte d’Ivoire

32. Nevirapine for the Prevention of Mother-to-Child Transmission of HIV: A Nation-Wide Coverage Survey in Côte d'Ivoire

33. Pregnancy Outcomes in Women Exposed to Efavirenz and Nevirapine: An Appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire

34. Évolution des conditions d’initiation du traitement antirétroviral des patients infectés par le VIH en Afrique de l’Ouest

35. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1

36. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries

37. Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of The West African Database to evaluate AIDS collaboration

38. Cervical cancer prevention in reproductive health services: knowledge, attitudes and practices of midwives in Côte d’Ivoire, West Africa

39. Antiretroviral therapy response among HIV-2 infected patients: a systematic review

40. Risk factors for cervical intraepithelial neoplasia in HIV-infected women on antiretroviral treatment in Côte d'Ivoire, West Africa

41. Feasibility and acceptability of rapid HIV screening in a labour ward in Togo

42. Cervical cancer screening by visual inspection in Côte d'Ivoire, operational and clinical aspects according to HIV status

43. Pharmacovigilance for antiretroviral drugs in Africa, lessons from a study in Abidjan, Cote d’Ivoire: Pharmacovigilance for antiretroviral drugs in Africa

44. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009

45. Strengthening health systems through HIV monitoring and evaluation in Sub-Saharan Africa

46. Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2 ▿

47. Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire

48. Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

49. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates

50. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire

Catalog

Books, media, physical & digital resources